18F-FDG PET-CT in Unknown-Source of Elevated Serum Carcinoembryonic Antigen (CEA) Level. | [Journal of College of Physicians and Surgeons--Pakistan : JCPSP • 2018]

Author(s):

1. Liwu Fu: Department of Nuclear Medicine, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, Henan, China-471000

2. Wei Li: Department of Nuclear Medicine, The First Affiliated Hospital of He'nan University of Science and Technology, Luoyang, Henan, China-471003

3. Xuezhi Tian: Department of Pathology, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, Henan, China-471000

Abstract:

Objective: To investigate the clinical value of 18F-FDG PET-CT in the diagnosis of malignant tumor when serum carcinoembryonic antigen (CEA) level is elevated for unknown primary lesion. Study Design: A descriptive study. Place and Duration of Study: Department of Nuclear Medicine, Luoyang Central Hospital Affiliated to Zhengzhou University, Henan, China, from March 2015 to March 2017. Methodology: A total of 120 cases of parallel 18F-FDG PET-CT examination with serum CEA level of patients with unexplained source examined were chosen. Those with a known disease or with incomplete record of clinical and/or relevant laboratory examinations were excluded. Pathological examination, results of clinical follow-up and other imaging tests constituted the clinical value of 18F-FDG PET-CT in the diagnosis of tumor. For patients who had underwent the determination of serum CEA more than twice, CEA doubling time (DT) was also calculated. The serum CEA level and CEA DT of benign versus malignant 18F-FDG PET-CT imaging results were compared. Results: Thirty (25.00%) cases were finally diagnosed as malignant tumors, and 90 (75.00%) cases were excluded labelled benign condition. There was one false positive case and one false negative case each with 18F-FDG PET-CT diagnosis. The sensitivity, specificity, accuracy, positive predictive value and negative predictive value were 96.7%, 98.9%, 98.3%, 96.7% and 98.9%, respectively. The serum CEA level of patients with positive 18F-FDG PET-CT imaging was higher than that of 18F-FDG PET-CT negative patients (p<0.001). The serum CEA DT of patients with positive 18F-FDG PET-CT imaging was shorter than that of 18F-FDG PET-CT negative patients (p<0.001). The receiver operating characteristic (ROC) curve analysis showed that the diagnostic efficacy of 18F-FDG PET-CT was best at serum CEA of 14.31 mg/L. Conclusion: 18F-FDG PET-CT imaging has high diagnostic value for patients with elevated serum CEA. For patients with serum CEA over 14.31 mg/L, the diagnostic value of 18F-FDG PET-CT for malignant tumors is more reliable.

Page(s): 910-913

DOI: DOI not available

Published: Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 28, Issue: 12, Year: 2018

Keywords:

Keywords are not available for this article.

References:

[1] MengQ,ShiS,LiangC,LiangD,XuW,JiS, 2017.Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis,Onco Targets Ther 10 4591 -8

[2] FischbachW,KielHJ, 1987.Follow-up of moderately elevated serum CEA levels in healthy patients,Cancer Detect Prev 10 109 -12

[3] LepidiH,Casalta J P , Gouriet F,CollartF,HabibG,RaoultD., 2008.Infective endocarditis incidentally discovered by pathological examination,J Clin Pathol 61 233 -4

[4] GoenseL,HeethuisSE,PsnVR,FemV,JjwL,MgehL, 2018.Correlation between functional imaging markers derived from diffusion-weighted MRI and 18F-FDG PET/CT in esophageal cancer,Nucl Med Commun 39 60 -7

[5] KimSJ,LeeTH,KimIJ,KimYK., 2009.Clinical implication of 18F-FDG PET-CTfor differentiated thyroid cancer in patients with negative diagnostic iodine-123 scan and elevated thyroglobulin,Eur J Radiol 70 17 -24

[6] VerberneCJ,NijboerCH,de BockGH,GrossmannI,WiggersT,HavengaK, 2012.Evaluation of the use of decision-support software in carcino-embryonic antigen (CEA)-based follow-up of patients with colorectal cancer,BMC Med Inform Decis Mak 12 1 -5

[7] KhanWN,TeglundS,BremerK,HammarströmS., 1992.The pregnancyspecific glycoprotein family of the immunoglobulin superfamily: identification of new members and estimation of family size,Genomics 12 780 -7

[8] InceAT,YildizK,BaysalB,DanaliogluA,KocamanO,TozluM, 2014.Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions,Turk J Gastroenterol 25 162 -9

[9] MahmoodM,KendiAT,AjmalS,FaridS,O'HoroJC,ChareonthaitaweeP, 2017.Meta-analysis of 18F-FDG PET-CT in the diagnosis of infective endocarditis,J Nucl Cardiol 1 -14

[10] SugaT,NakamotoY,SagaT,HigashiT,HaraT,IshizuK, 2010.Prevalence of positive FDG PET findings in patients with high CEA levels,Ann Nucl Med 24 433 -9

[11] LiW,YinW,OuR,ChenT,XiongL,ChengD, 2016.The value of F-18 fluorodeoxyglucose positron emission tomography/ computed tomography in asymptomatic examinees with unexplained elevated blood carcinoembryonic antigen levels,Eur J Nucl Med Mol Imaging 43 675 -81

[12] VerberneCJ,WiggersT,VermeulenKM,JongKP, 2013.Detection of recurrences during follow-up after liver surgery for colorectal metastases: both carcinoembryonic antigen (CEA) and imaging are important,Ann Surg Oncol 20 457 -63

[13] LiBG,MaDQ,XianZY,GuanJ,LuoKJ,FanQW, 2012.The value of multislice spiral ct features of cavitary walls in differentiating between peripheral lung cancer cavities and single pulmonary tuberculous thick-walled cavities,Br J Radiol 85 147 -52

[14] XieX,DijkstraAE,VonkJM,OudkerkM,VliegenthartR,GroenHJ, 2014.Chronic respiratory symptoms associated with airway wall thickening measured by thin-slice low-dose CT,Am J Roentgenol 203 383 -90

[15] NageshCM,SaxenaA,PatelC,KarunanithiS,NadigM,MalhotraA, 2015.The role of 18F fluorodeoxyglucose positron emission tomography (18F-FDG-PET) in children with rheumatic carditis and chronic rheumatic heart disease,Nucl Med Rev Cent East Eur 18 25 -8

[16] AyanAK,ErdemciB,OrsalE,BayraktutanZ,AkpinarE,TopcuA, 2015.Is there any correlation between levels of serum ostepontin, CEA, and FDG uptake in lung cancer patients with bone metastasis?,Rev Esp Med Nucl Imagen Mol 35 102 -6

[17] EndoK,OriuchiN,HiguchiT,IidaY,HanaokaH,MiyakuboM, 2006.PET and PET-CT using 18F-FDG in the diagnosis and management of cancer patients,Int J Clin Oncol 11 286 -96

[18] GiovanellaL,TrimboliP,VerburgFA,TregliaG,PiccardoA,FoppianiL, 2013.Thyroglobulin levels and thyroglobulin doubling time independently predict a positive 18F-FDG PET-CT scan in patients with biochemical recurrence of differentiated thyroid carcinoma,Eur J Nucl Med Mol Imaging 40 874 -80

[19] ZhangZF,MaJQ,SunN, 2004.The function of the level of serum carcinoembryonic antigen on early recurrence of nonsmall cell lung cancer,Chin J Surg 42 817 -9

[20] ZhaoWH,LiuYP,YuQT,ZhouSZ,SongXQ, 2015.Analysis of the related factors of serum CEA level and brain metastases in patients with advanced non-small cell lung cancer,J Guangxi Med Univ 32 401 -4

Citations

Downloads

Views